Physician
Rheumatology
John Tesser practices Rheumatology. He attended University of Rochester School of Medicine and Dentistry. He received 6 awards: "Top Doctors:Arizona State", "CMS Meaningful Use Stage 1 Certification", "Fellow", "Super Doctor", "Top MD" and "Fellow (FACR)". John R. Tesser is a published physician. He has 27 publications published. The most current publication "Antipolymer antibody reactivity in a subset of patients with fibromyalgia correlates with severity." John Tesser is registered with Medicare and accepts Medicare payments.
Publications
- Etanercept versus methotrexate in patients with early rheumatoid Arthritis: two-year radiographic and clinical outcomes.
- Safety of extended treatment with anakinra in patients with rheumatoid Arthritis.
- How often does Lateral spine DXA detect low bone mass in patients with both normal PA spine and hip?
- Effects of consuming foods containing oat beta-glucan on blood pressure, carbohydrate metabolism and biomarkers of oxidative stress in men and women with elevated bloo...
- Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid ...
- The prevalence of autoantibodies in symptomatic and asymptomatic patients with breast implants and patients with Fibromyalgia.
- Combination therapy with cyclosporine and methotrexate in severe rheumatoid Arthritis. The Methotrexate-Cyclosporine Combination Study Group.
- How the new Hologic hip normal reference values affect the densitometric diagnosis of Osteoporosis.
- Clinical and immunologic effects of a PRIMATIZED anti-CD4 monoclonal antibody in active rheumatoid Arthritis: results of a phase I, single dose, dose escalating trial.
- Combination treatment of severe rheumatoid Arthritis with cyclosporine and methotrexate for forty-eight weeks: an open-label extension study. The Methotrexate-Cyclospo...
- A 4-week randomized study of acetaminophen extended-release vs rofecoxib in knee osteoArthritis.
- Evaluating the adequacy of disease control in patients with rheumatoid Arthritis: a RAND appropriateness panel.
- Use of antipolymer antibody assay in recipients of silicone breast implants.
- Chronic liver Disease and Still's Disease.
- The liver in rheumatic Diseases.
- The clinical significance of anticytoplasmic antibodies found on fluorescent antinuclear antibody testing.
- An autopsy study of the prevalence of monosodium urate and Calcium pyrophosphate dihydrate crystal deposition in first metatarsophalangeal joints.
- A comparison of etanercept and methotrexate in patients with early rheumatoid Arthritis.
- Antipolymer antibody reactivity in a subset of patients with Fibromyalgia correlates with severity.
- Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid Arthritis.
- The evolution of biomarkers in rheumatoid Arthritis: from clinical research to clinical care.
- CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized monoclonal anti-CD4 treatment of active rheumatoid Arthritis.
- Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists.
- The safety of anakinra in high-risk patients with active rheumatoid Arthritis: six-month observations of patients with comorbid conditions.
- Concomitant medication use in a large, international, multicenter, placebo controlled trial of anakinra, a recombinant interleukin 1 receptor antagonist, in patients w...
- Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid Arthritis: A large, international, multicenter, placebo-co...
Schools
University Of Rochester School Of Medicine and Dentistry
Maricopa Med Center
Bowman Gray
Procedures Preformed
- Joint Drainage
- Myofascial Trigger Point Injection
- Steroid Injection
- Trigger Point Injection
- View All
Conditions Treated
- Achilles Tendinitis
- Adhesive Capsulitis
- Amyloidosis
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
Accepted Insurances
Awards
- Top Doctors:Arizona State
- CMS Meaningful Use Stage 1 Certification
- Fellow
- Super Doctor
- Top MD
- Fellow (FACR)
Education
-
Maricopa Medical Center
-
University of Rochester School of Medicine and Dentistry
Hospital
-
Phoenix Children's Hospital
Drug Facts
| NPI NUMBER |
|
1427049220 |
| NPPES Provider LastName |
|
TESSER |
| NPPES Provider FirstName |
|
JOHN |
| NPPES Provider ZIPCode |
|
850329306 |
| NPPES Provider State |
|
AZ |
| Specialty Description |
|
Rheumatology |
| Total Claim Count |
|
2482.0 |
| Distinct Opioid Count |
|
7.0 |
| Opioid Claim Count |
|
542.0 |
| Percent Opioid Claims |
|
21.84 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1427049220 |
| Last Name Of The Provider |
TESSER |
| First Name Of The Provider |
JOHN |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.